Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.63B | 5.86B | 5.74B | 4.54B | 3.98B | Gross Profit |
1.65B | 5.02B | 5.48B | 4.33B | 3.81B | EBIT |
977.79M | 1.44B | 1.64B | 961.15M | 540.13M | EBITDA |
1.92B | 2.18B | 2.34B | 1.63B | 1.20B | Net Income Common Stockholders |
628.71M | 924.47M | 1.12B | 610.86M | 442.05M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.54B | 2.06B | 2.70B | 1.19B | 494.35M | Total Assets |
19.06B | 18.12B | 17.30B | 14.65B | 13.44B | Total Debt |
6.33B | 6.75B | 6.10B | 4.76B | 4.73B | Net Debt |
4.79B | 4.69B | 3.39B | 3.57B | 4.23B | Total Liabilities |
11.89B | 11.60B | 11.41B | 9.80B | 9.22B | Stockholders Equity |
7.17B | 6.53B | 5.89B | 4.85B | 4.22B |
Cash Flow | Free Cash Flow | |||
-1.54B | -994.29M | -190.30M | 93.92M | -1.23B | Operating Cash Flow |
1.45B | 1.73B | 1.95B | 1.54B | 1.08B | Investing Cash Flow |
-2.05B | -2.42B | -1.87B | -1.13B | -1.77B | Financing Cash Flow |
66.53M | 59.80M | 1.43B | 287.35M | 512.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $43.25B | 17.23 | 30.17% | 1.04% | 7.20% | 4.56% | |
74 Outperform | $2.64B | 11.13 | 22.80% | 1.78% | 7.31% | 91.99% | |
69 Neutral | $5.98B | 12.66 | 16.41% | 2.26% | 6.21% | 47.05% | |
64 Neutral | $4.28B | 11.80 | 5.30% | 250.74% | 4.12% | -9.02% | |
61 Neutral | $11.61B | 30.80 | 5.61% | ― | 0.98% | -35.16% | |
61 Neutral | $3.27B | 15.53 | 9.60% | 2.42% | 8.34% | -63.02% | |
56 Neutral | $3.30B | 36.17 | 15.74% | 1.22% | -3.52% | -46.60% |